Medtronic Plc Valuation

MDTC34 Stock  BRL 261.58  5.18  1.94%   
At this time, the firm appears to be overvalued. Medtronic plc secures a last-minute Real Value of R$216.7 per share. The latest price of the firm is R$261.58. Our model forecasts the value of Medtronic plc from analyzing the firm fundamentals such as Profit Margin of 0.14 %, current valuation of 625.84 B, and Return On Equity of 0.0833 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
261.58
261.6261.58216.7216.7261.6261.58258.5258.52
Please note that Medtronic Plc's price fluctuation is very steady at this time. Calculation of the real value of Medtronic plc is based on 3 months time horizon. Increasing Medtronic Plc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Medtronic Plc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medtronic Stock. However, Medtronic Plc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  261.58 Real  216.7 Hype  261.58 Naive  258.52
The real value of Medtronic Stock, also known as its intrinsic value, is the underlying worth of Medtronic plc Company, which is reflected in its stock price. It is based on Medtronic Plc's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Medtronic Plc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
215.06
Downside
216.70
Real Value
287.74
Upside
Estimating the potential upside or downside of Medtronic plc helps investors to forecast how Medtronic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medtronic Plc more accurately as focusing exclusively on Medtronic Plc's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
258.45265.57272.69
Details
Hype
Prediction
LowEstimatedHigh
259.94261.58263.22
Details
Naive
Forecast
LowNext ValueHigh
256.88258.52260.16
Details

Medtronic Plc Total Value Analysis

Medtronic plc is now anticipated to have takeover price of 625.84 B with market capitalization of 589.18 B, debt of 20.32 B, and cash on hands of 10.6 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Medtronic Plc fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
625.84 B
589.18 B
20.32 B
10.6 B

Medtronic Plc Investor Information

The book value of the company was now reported as 19.5. The company recorded earning per share (EPS) of 8.13. Medtronic plc last dividend was issued on the 20th of December 2022. Based on the measurements of operating efficiency obtained from Medtronic Plc's historical financial statements, Medtronic plc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.

Medtronic Plc Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medtronic Plc has an asset utilization ratio of 34.83 percent. This suggests that the Company is making R$0.35 for each dollar of assets. An increasing asset utilization means that Medtronic plc is more efficient with each dollar of assets it utilizes for everyday operations.

Medtronic Plc Profitability Analysis

The company reported the revenue of 31.69 B. Net Income was 5.04 B with profit before overhead, payroll, taxes, and interest of 21.71 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Medtronic Plc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Medtronic Plc and how it compares across the competition.

About Medtronic Plc Valuation

The stock valuation mechanism determines Medtronic Plc's current worth on a weekly basis. Our valuation model uses a comparative analysis of Medtronic Plc. We calculate exposure to Medtronic Plc's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medtronic Plc's related companies.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. MEDTRONIC DRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 90000 people.

8 Steps to conduct Medtronic Plc's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Medtronic Plc's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medtronic Plc's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Medtronic Plc's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Medtronic Plc's revenue streams: Identify Medtronic Plc's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Medtronic Plc's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Medtronic Plc's growth potential: Evaluate Medtronic Plc's management, business model, and growth potential.
  • Determine Medtronic Plc's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medtronic Plc's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Medtronic Stock analysis

When running Medtronic Plc's price analysis, check to measure Medtronic Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic Plc is operating at the current time. Most of Medtronic Plc's value examination focuses on studying past and present price action to predict the probability of Medtronic Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic Plc's price. Additionally, you may evaluate how the addition of Medtronic Plc to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios